Document Detail

Requirements for Parkinson's disease pharmacotherapy from the patients' perspective: a questionnaire-based survey.
MedLine Citation:
PMID:  22686959     Owner:  NLM     Status:  Publisher    
Abstract Objective: Knowledge of patients' treatment needs is an important requirement for comprehensive long-term patient care. The objective of this investigation was to assess the requirements of patients with Parkinson's disease (PD) regarding pharmacotherapy. Methods: A total of 17,500 members of the German Parkinson Association were given the opportunity to anonymously answer a questionnaire about their health-related quality of life, PD pharmacotherapy and their improvement suggestions for new PD medication. Results: Answers from 6351 patients were available for analysis. The majority (87.2%) of patients were older than 60 years; 88.9% had been diagnosed with PD for longer than 3 years and 84.4% selected one of the three most severe categories (categories 1-3 on a 6-point scale) when rating the impact of PD on their quality of life. Symptoms that were regarded as very important for improvement with pharmacotherapy included motor fluctuations (66.3%), early morning akinesia (55.4%) and sleep disturbances (43.5%). Properties of a new PD medication that were rated as very important included continuous drug delivery over 24 hours (66.6%) and 24-hour symptom control (55.8%). The majority of patients used physicians (84.2%) and/or self-help groups (69.4%) to obtain information about PD. Topics of particular interest included comorbid diseases (78.3%), mobility and exercise (77.3%) and research (53%). Conclusion: PD has a major impact on patients' quality of life. From the patient's perspective, PD pharmacotherapy needs to address a range of symptoms including not only motor symptoms, but also nonmotor symptoms such as sleep disturbances. In selecting the most appropriate treatment regimen, patient preference is an important consideration.
Ullrich Wüllner; Gerd Fuchs; Nicole Reketat; Olaf Randerath; Jan Kassubek
Related Documents :
21558859 - Descriptive analysis of oxygen use in australian emergency departments.
19827989 - Therapy of community-acquired acute bacterial meningitis: the clock is running.
2845779 - Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with...
956879 - Restricted fluid intake. rational management of the neurosurgical patient.
21817969 - The impact of discharging minimally injured trauma patient: does age play a role in tra...
12458049 - Increased expression of the th1-inducing cytokines interleukin-12 and interleukin-18 in...
21558859 - Descriptive analysis of oxygen use in australian emergency departments.
20373909 - Domiciliary experience of the target inhalation mode (tim) breathing maneuver in patien...
16908219 - Treatment of patients with coexisting epileptic and nonepileptic seizures.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-11
Journal Detail:
Title:  Current medical research and opinion     Volume:  -     ISSN:  1473-4877     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Myopathy during statin-therapy in the daily practice of an outpatient cardiology clinic: prevalence,...
Next Document:  Behavioral Characteristics of Internet Gamblers Who Trigger Corporate Responsible Gambling Intervent...